Canonical: https://neurodiversity.gklijs.tech/i/fa25bcd6645e

# Collegium Pharmaceutical (COLL) Repositioning: Shifting Focus from Pain Management to ADHD

Yahoo Finance

2 November 2026 (2026-11-02)

Collegium Pharmaceutical is shifting its focus from pain management to ADHD, signaling a strategic repositioning in its business approach. The company's stock has experienced a decline, reflecting market reactions to this change in emphasis. The Third Avenue Small-Cap Value Fund's Q3 2026 performance highlights mixed contributions from various stocks, with Collegium Pharmaceuticals being a detractor.

[Read at Yahoo Finance](<https://finance.yahoo.com/healthcare/articles/collegium-pharmaceutical-coll-repositioning-shifting-140840416.html>)

All articles from [2 November 2026](</2026/11/02>). Summaries are AI-generated and may contain errors; the linked article is the authority.

## Get this news by email

Daily or as a weekly roundup in your inbox. You confirm your address first; every email has an unsubscribe link. For another topic or language, use the [subscribe page](</subscribe>).

## More to read

- [Topics](</topics>)
- [Agenda](</agenda>)
- [Subscribe](</subscribe>)
